It Kills That: Cramer Won’t Recommend Pfizer 7% Yield
Jim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Need ways to earn fast for immediate needs? Dive into our resourceful suggestions to enhance your cash flow quickly.
18,509 articlesJim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Choosing the right AI exposure can feel tricky. This article breaks down which better artificial intelligence path fi...
When CODA reports its Q2 2026 results, the focus shifts from headlines to signals—backlog, margins, and customer wins...
Meta's AI model projects a substantial rally for gold and silver by end-2026, framing both as twin bets on a shared m...
A 61-year-old engineer worries that being laid off before the Social Security cutoff could erase years of earnings. T...
As Apple eyes a leadership transition, analysts debate whether Apple stock will outpace the S&P 500 in the new CEO’s ...
ON Semiconductor rides AI data-center demand and EV silicon trends to extend its rally, but analysts warn that valuat...
Aehr Test Systems faces a pivotal Q4 print after the market closes, with AI burn-in demand and bookings in focus as t...
New to rental investing? This beginner-friendly guide breaks down long-term rentals versus short-term rentals, with r...
A retiree can target about $5,000 in monthly income from a $1 million Traditional IRA by blending three income ETFs, ...
Five cities are in a high-stakes chase to land a blockbuster deal tied to LeBron James, hoping for lasting local grow...
New York’s one-year moratorium on hyperscale data centers upends AI infrastructure planning and tests how governments...